Key facts
- It has raised $237.6M; the latest was Later Stage VC ($3.4M) in Dec 2025.
- Notable investors include KB Investment, Korea Investment Partners, Korea Development Bank, Hana Ventures, Mashup Ventures — 31 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 31 names
- ·Watchlist + deal alerts for Humanscape
- ·The full record, as it builds
Funding rounds
No funding rounds for Humanscape are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Humanscape
Developer of a blockchain-based health data platform designed to help cure diseases. The company's platform allows users to share comprehensive health data from genotype and clinical to phenotype data, systematically compiling it into a complete, ready-to-use data set and providing information about various incurable and rare diseases, enabling medical practitioners to find and develop drugs and improve the treatment of patients.
- Sector
- Healthcare
- HQ
- Seoul, South Korea
- Founded
- 2016
- Employees
- 79
- Website
- humanscape.io/
- Ownership
- Privately Held (backing)
Humanscape doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Humanscape shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Humanscape in its N-PORT filings yet. We sweep new filings monthly.